检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]上海中医药大学附属曙光医院,上海200021
出 处:《上海中医药杂志》2000年第7期15-16,共2页Shanghai Journal of Traditional Chinese Medicine
摘 要:观察平消胶囊配合化疗治疗晚期肿瘤患者的疗效及其免疫指标的变化。将 5 5例恶性肿瘤随机分为治疗组 (平消胶囊 +化疗 ) 35例 ,对照组 (白介素 Ⅱ +化疗 ) 2 0例。结果 :经治疗观察 2个月后 ,治疗组CD3 、CD4 、CD8、NK细胞等免疫指标有不同程度提高 ,与对照组比较有显著差异 (P <0 .0 5 ,P <0 .0 1) ,但在晚期肿瘤患者的生存期、毒副反应等方面 ,两组比较无显著性差异。提示平消胶囊配合化疗能提高晚期肿瘤患者免疫功能。To observe the clinical effects and change of immune indexes in patients with mid and late tumor treated by “Pingxiao capsule” and chemotherapy,55 cases of malignant tumor were randomly divided into treatment group (35 cases treated by “Pingxiao capsule” and chemotherapy) and control group (20 cases treated by interleukin Ⅱ and chemotherapy).After 2 month treatment,in treatment group such immune indexes as CD 3,CD 4,CD 8 and NK cell increased at different degrees and there were great differences[WT6BX](P<0.05~0.01)[WT6BZ] in comparison with control group;but in patients with late tumor,there were no differences in survival time and toxic and negative effects between two groups.The results revealed that “Pingxiao capsule” and chemotherapy could increase the immunity in patients with late tumor.
分 类 号:R273.305.3[医药卫生—中西医结合]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.26